Search research articles
Contact Us
Filters
Showing results (561-570 of 659) with videos related to
Page
of 66
Sort By:
Leukemia & Lymphoma
|
September 21, 2020
Translocation t(1;19)(q23;p13) in adult acute lymphoblastic leukemia - a distinct subtype with favorable prognosis
Musa Yilmaz, Hagop M Kantarjian, Gokce Toruner, et al.
Blood Advances
|
March 20, 2026
Mutations in Isocitrate Dehydrogenase Portend a Poor Prognosis in Adult Patients with Acute Lymphoblastic Leukemia
Hannah Goulart, Nicholas J Short, Gautam Borthakur, et al.
Blood Cancer Journal
|
May 2, 2022
Hypomethylating agent and venetoclax with FLT3 inhibitor "triplet" therapy in older/unfit patients with FLT3 mutated AML
Musa Yilmaz, Hagop Kantarjian, Nicholas J Short, et al.
The Lancet. Haematology
|
April 28, 2022
Venetoclax combined with induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia: a post-hoc, propensity score-matched, cohort study
Curtis A Lachowiez, Patrick K Reville, Hagop Kantarjian, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 30, 2025
Outcomes of Patients With IDH1-Mutated Myeloid Neoplasms Treated With Olutasidenib
Kelly S Chien, Sanam Loghavi, Koji Sasaki, et al.
Leukemia & Lymphoma
|
July 19, 2017
A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia
Nicholas J Short, Hagop Kantarjian, Farhad Ravandi, et al.
American Journal of Hematology
|
February 24, 2024
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial
Issa F Khouri, Kamal Alzahrani, Hagop Kantarjian, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 15, 2021
Myeloid/lymphoid neoplasms with FLT3 rearrangement
Guilin Tang, Wayne Tam, Nicholas J Short, et al.
Blood
|
August 5, 2017
Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN
Elias Jabbour, Nicholas J Short, Guillermo Montalban-Bravo, et al.
British Journal of Haematology
|
October 10, 2025
CD123 expression and its correlation with mutation profile in acute myeloid leukaemia
Roberta S Azevedo, Sa A Wang, David M Swanson, et al.
Page
of 66
Search research articles
Search
Showing results (561-570 of 659) with videos related to
Sort By:
Page
of 66
Leukemia & Lymphoma
|
September 21, 2020
Translocation t(1;19)(q23;p13) in adult acute lymphoblastic leukemia - a distinct subtype with favorable prognosis
Musa Yilmaz, Hagop M Kantarjian, Gokce Toruner, et al.
Blood Advances
|
March 20, 2026
Mutations in Isocitrate Dehydrogenase Portend a Poor Prognosis in Adult Patients with Acute Lymphoblastic Leukemia
Hannah Goulart, Nicholas J Short, Gautam Borthakur, et al.
Blood Cancer Journal
|
May 2, 2022
Hypomethylating agent and venetoclax with FLT3 inhibitor "triplet" therapy in older/unfit patients with FLT3 mutated AML
Musa Yilmaz, Hagop Kantarjian, Nicholas J Short, et al.
The Lancet. Haematology
|
April 28, 2022
Venetoclax combined with induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia: a post-hoc, propensity score-matched, cohort study
Curtis A Lachowiez, Patrick K Reville, Hagop Kantarjian, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 30, 2025
Outcomes of Patients With IDH1-Mutated Myeloid Neoplasms Treated With Olutasidenib
Kelly S Chien, Sanam Loghavi, Koji Sasaki, et al.
Leukemia & Lymphoma
|
July 19, 2017
A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia
Nicholas J Short, Hagop Kantarjian, Farhad Ravandi, et al.
American Journal of Hematology
|
February 24, 2024
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial
Issa F Khouri, Kamal Alzahrani, Hagop Kantarjian, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 15, 2021
Myeloid/lymphoid neoplasms with FLT3 rearrangement
Guilin Tang, Wayne Tam, Nicholas J Short, et al.
Blood
|
August 5, 2017
Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN
Elias Jabbour, Nicholas J Short, Guillermo Montalban-Bravo, et al.
British Journal of Haematology
|
October 10, 2025
CD123 expression and its correlation with mutation profile in acute myeloid leukaemia
Roberta S Azevedo, Sa A Wang, David M Swanson, et al.
Page
of 66